t-Branch现成多分支支架用于既往肾下主动脉修复后再次干预的短期结果
该回顾性双中心研究纳入32例既往肾下主动脉修复后行t-Branch支架腔内修复胸腹/肾旁动脉瘤的患者,技术成功率97%,早期死亡率13%,脊髓缺血率22%,1年生存率73%,无再干预率90%。
要点
- t-Branch用于既往肾下主动脉修复后再次干预技术可行,早期结果可接受。
- 早期死亡率13%,脊髓缺血率22%,其中永久性神经缺损4例。
- 1年累积生存率73%,无再干预率90%,靶血管通畅率97.5%。
核心结论
- t-Branch现成多分支支架用于既往肾下主动脉修复后主动脉疾病治疗可行,早期发病率和死亡率可接受。
研究设计与样本
- 回顾性双中心研究,纳入2010年1月至2018年8月连续32例既往肾下主动脉修复后使用t-Branch支架行腔内修复的患者。
主要发现
- 技术成功率97%(31/32),早期死亡率13%,脊髓缺血率22%(7/32),其中永久性神经缺损4例、暂时性3例。
- 早期靶血管通畅率100%,内漏率9%(3/32),包括2例II型内漏和1例III型内漏。
- 平均随访5.4±5.9个月,6个月和12个月累积生存率分别为82%和73%,无主动脉相关死亡率为92%。
- 随访期间6个月和12个月累积无再干预率均为90%,总体靶血管通畅率分别为100%和97.5%。
临床怎么用
- 对于既往肾下主动脉修复后需再次干预的胸腹/肾旁动脉瘤患者,可考虑使用t-Branch现成多分支支架,但需注意脊髓缺血风险。
局限性
- 回顾性设计、样本量小(32例)、随访时间短(平均5.4个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to evaluate the outcome of t-Branch (Cook Medical, Bloomington, Ind) stent graft for the treatment of thoracoabdominal and pararenal aortic aneurysms in patients who had previous infrarenal aortic repair. METHODS: A retrospective two-center study was undertaken. All consecutive patients who underwent endovascular repair using t-Branch stent graft after previous infrarenal aortic repair between January 2010 and August 2018 were included. Demographics, past medical history, cardiovascular risk factors, and intraoperative and perioperative details were recorded. Technical success and early (30-day) mortality, morbidity, target vessel patency, and presence of endoleak were analyzed. During the first year of follow-up, survival, freedom from reintervention, and patency rates were recorded. RESULTS: There were 32 patients (mean age, 74 ± 7 years; 81% male) included in the study; 24 (75%) patients had prior open surgical repair, and 8 (25%) patients had undergone standard endovascular aneurysm repair. The index operation was performed 9 ± 5 years earlier, including 10 ± 5 years for open surgical repair and 8 ± 6 years for endovascular aortic repair. The indication was progression of the disease in 26 patients (81%) and type IA endoleak in 6 patients (19%). The total number of target vessels incorporated was 117 arteries (3.8 ± 0.6 target vessels per patient). Eleven patients had only three vessels incorporated; celiac trunk was occluded in three patients, and eight patients had one functioning kidney. Technical success rate was 97% (31/32). There was a single technical failure in one patient who had a type IA endoleak after endovascular repair with suprarenal fixation. The stenotic right renal artery was not catheterized at the initial procedure, and retrograde access was achieved through a right subcostal incision 3 days later with successful completion of the repair. Early mortality rate was 13%, and spinal cord ischemia rate was 22% (7/32); four patients had permanent and three had transient neurologic deficits. Early target vessel patency was 100%, and the rate of any endoleak was 9% (3/32); two patients had type II endoleaks and one patient had type III endoleak. The mean follow-up was 5.4 ± 5.9 months. The cumulative survival rate was 82% and 73% at 6 and 12 months, respectively. The freedom from aorta-related mortality was 92% at 6 and 12 months. The cumulative freedom from reintervention during follow-up was 90% at 6 and 12 months. The overall target vessel patency rate was 100% and 97.5% at 6 and 12 months, respectively. CONCLUSIONS: The use of t-Branch off-the-shelf stent graft for the treatment of aortic disease in patients who had previous infrarenal aortic repair appears to be feasible, with acceptable early outcomes in terms of morbidity and mortality.
引用
- Eleshra A, Oderich GS, Spanos K, et al. Short-term outcomes of the t-Branch off-the-shelf multibranched stent graft for reintervention after previous infrarenal aortic repair. J Vasc Surg. 2020. PMID: 32423775. doi:10.1016/j.jvs.2020.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。